Mukka Proteins Share Price Today (MUKKA)
TODAY IN ONE LINE
MUKKA fell 1.6% on average volume, lagging Nifty's 0.8% move.
With a market cap of ₹686.4 Cr., it trades at a P/E of 13.29. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Mukka Proteins flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 53.3% YoY
- ●Reasonable ValuationTrading at a moderate P/E of 14.0x
- ●High Promoter HoldingPromoters hold 73.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.02x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 0.3% YoY
Latest Mukka Proteins News
What changed recently?
Recent events, corporate actions, and announcements.
Mukka Proteins Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Mukka Proteins Limited, framed against the sector median so the premium or discount is obvious at a glance.
Mukka Proteins Limited trades at a P/E of 13.29× and P/B of 1.39×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Mukka Proteins Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Mukka Proteins Limited — derived from the live tape, not yesterday's close.
Mukka Proteins Limited last traded at ₹22.58 with an intraday range of ₹21.5–₹23.49 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹22.58| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 27.53 | +4.95 | +21.91% |
| R3 | 25.54 | +2.96 | +13.09% |
| R2 | 24.51 | +1.93 | +8.56% |
| R1 | 23.55 | +0.97 | +4.28% |
| PIVOT | 22.52 | -0.06 | -0.25% |
| CURRENT | 22.58 | — | — |
| S1 | 21.56 | -1.02 | -4.53% |
| S2 | 20.53 | -2.05 | -9.06% |
| S3 | 19.57 | -3.01 | -13.35% |
| S4 | 17.58 | -5.00 | -22.16% |
MUKKA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹21.5–₹23.49
Trading Inside opening range
Mukka Proteins Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Mukka Proteins Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Mukka Proteins Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹686.4 Cr. and reported EPS of ₹1.74.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,006 | 1,449 ▲ 44.0% |
| Sales Growth YoY %Derived | -27.06% | 44.02% |
| Other Income | 15 | 29 ▲ 89.8% |
| Total Income | 1,022 | 1,478 ▲ 44.7% |
| 775 | 1,169 ▲ 50.9% | |
| Gross ProfitDerived | 232 | 280 ▲ 20.9% |
| Gross Margin %Derived | 23.03% | 19.33% |
| 137 | 166 ▲ 21.0% | |
| EBITDA (Operating Profit)Derived | 95 | 115 ▲ 20.8% |
| OPM %Derived | 9.43% | 7.91% |
| 51 | 70 ▲ 38.2% | |
| Profit Before Tax (PBT) | 59 | 73 ▲ 23.4% |
| 12 | 18 ▲ 48.4% | |
| Effective Tax %Derived | 20.56% | 24.71% |
| Total Profit for Period | 48 | 57 ▲ 18.7% |
| Less: Non-controlling Interests | 2 | 5 ▲ 207.0% |
| Net Profit (Owner's PAT)Derived | 46 | 52 ▲ 12.1% |
| Net Profit Margin %Derived | 4.62% | 3.59% |
| PAT Growth YoY %Derived | -33.68% | 12.05% |
| Earnings Per Share (EPS ₹) | 1.55 | 1.74 ▲ 12.3% |
| Diluted Shares Outstanding (Cr) | 30 | 30 ▲ 0.0% |
| Share of Profit from Associates/JVs | 1 | 2 ▲ 93.6% |
| Other Comprehensive Income (Net of Tax) | -0 | -1 ▼ 87.7% |
| Total Expenses (incl. D&A & Interest) | 962 | 1,405 ▲ 46.0% |
| Material Cost % of RevenueDerived | 91.03% | 98.71% |
| Employee Cost % of RevenueDerived | 3.21% | 2.81% |
| Other Cost % of RevenueDerived | 10.39% | 8.61% |
| Interest Coverage (x)Derived | 2.18x | 1.83x |
| Period | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|
| Revenue from Operations | 1,380 | 1,006 ▼ 27.1% | 1,449 ▲ 44.0% | |
| Sales Growth YoY %Derived | — | -27.06% | 44.02% | |
| Other Income | 19 | 15 ▼ 22.2% | 29 ▲ 89.8% | |
| Total Income | 1,399 | 1,022 ▼ 27.0% | 1,478 ▲ 44.7% | |
1,136 | 775 ▼ 31.8% | 1,169 ▲ 50.9% | ||
| Gross ProfitDerived | 244 | 232 ▼ 5.1% | 280 ▲ 20.9% | |
| Gross Margin %Derived | 17.71% | 23.03% | 19.33% | |
139 | 137 ▼ 1.4% | 166 ▲ 21.0% | ||
| EBITDA (Operating Profit)Derived | 105 | 95 ▼ 10.0% | 115 ▲ 20.8% | |
| OPM %Derived | 7.64% | 9.43% | 7.91% | |
37 | 51 ▲ 35.7% | 70 ▲ 38.2% | ||
| Profit Before Tax (PBT) | 87 | 59 ▼ 32.3% | 73 ▲ 23.4% | |
13 | 12 ▼ 7.5% | 18 ▲ 48.4% | ||
| Effective Tax %Derived | 15.04% | 20.56% | 24.71% | |
| Total Profit for Period | 74 | 48 ▼ 35.3% | 57 ▲ 18.7% | |
| Less: Non-controlling Interests | 4 | 2 ▼ 61.5% | 5 ▲ 207.0% | |
| Net Profit (Owner's PAT)Derived | 70 | 46 ▼ 33.7% | 52 ▲ 12.1% | |
| Net Profit Margin %Derived | 5.08% | 4.62% | 3.59% | |
| PAT Growth YoY %Derived | — | -33.68% | 12.05% | |
| Earnings Per Share (EPS ₹) | 2.34 | 1.55 ▼ 33.8% | 1.74 ▲ 12.3% | |
| Diluted Shares Outstanding (Cr) | 30 | 30 ▲ 0.0% | 30 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | 1 | 2 ▲ 93.6% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▼ 0.9% | -1 ▼ 87.7% | |
| Total Expenses (incl. D&A & Interest) | 1,312 | 962 ▼ 26.6% | 1,405 ▲ 46.0% | |
| Material Cost % of RevenueDerived | 96.16% | 91.03% | 98.71% | |
| Employee Cost % of RevenueDerived | 2.13% | 3.21% | 2.81% | |
| Other Cost % of RevenueDerived | 7.94% | 10.39% | 8.61% | |
| Interest Coverage (x)Derived | 3.71x | 2.18x | 1.83x |
Mukka Proteins segment analysis : revenue and profit mix.
Disclosed business segments at Mukka Proteins with their share of revenue and profit, switchable between consolidated and standalone reporting.
Mukka Proteins discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Mukka Proteins Limited.
Our AI distills the core fundamental drivers supporting Mukka Proteins Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Mukka Proteins Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding stable 73.33% ensures strong management alignment and long-term commitment.
Latest quarterly EPS grew 51.7% YoY, demonstrating earnings acceleration momentum.
TTM EPS grew 53.3% YoY, showcasing sustained profitability improvement trajectory.
P/E 13.99x trades below sector median, offering attractive valuation entry point.
Operating margin 6.98% exceeds peers Ajooni and Narmada, indicating operational efficiency.
Key Risks.
Operating cash flow negative ₹160.99 Cr annually, indicating persistent cash burn.
Quarterly sales declined 0.25% YoY despite EPS growth, revenue stagnation evident.
Zero dividend yield provides no income stream for shareholders seeking returns.
FII holdings fell from 6.46% to 1.70%, signaling weak institutional conviction.
Cash position critically low at ₹1.94 Cr, raising acute liquidity stress concerns.
Flip Conditions.
Valuation risk. a P/E above 17 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 2.06. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Mukka Proteins Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Mukka Proteins Limited is highlighted for quick read-across.
Quick Compare
Mukka Proteins Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Mukka Proteins Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Mukka Proteins Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Mukka Proteins Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Mukka Proteins Limited stood at 65.1% of traded volume, against a 20-day average of 60.6%.
Mukka Proteins announcements: results, concalls, ratings, M&A.
Filings Mukka Proteins sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Mukka Proteins files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 91 documents below.
Shareholders meeting
Mukka Proteins Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange…
Agreements
Mukka Proteins Limited has informed the Exchange about execution of loan agreement.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mukka Proteins Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended…
Copy of Newspaper Publication
Mukka Proteins Limited has informed the Exchange about Copy of Newspaper Publication of Corrigendum to the notice of Postal Ballot dated June 12,…
Shareholders meeting
Mukka Proteins Limited has informed the Exchange regarding issuance of Corrigendum to the Notice of Postal Ballot.
Investor decks & rating reports.
Mukka Proteins dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Mukka Proteins has declared, sequenced by announce and record date.
Mukka Proteins corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Mukka Proteins Limited: business, sector, key facts.
What Mukka Proteins Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Mukka Proteins Limited operates in the Animal Feed industry under the Fast Moving Consumer Goods sector, listed as NSE: MUKKA, BSE: 544135.
Mukka Proteins Limited is an Indian company specializing in the manufacturing and sale of fish-based protein products. Their core business centers around providing high-quality ingredients derived from fish processing, serving a diverse range of industries both domestically and internationally.
The company's product portfolio includes key components like fish meal, fish oil, and fish soluble paste. These products are primarily utilized as valuable ingredients in the animal feed sector, catering to the needs of animal feed manufacturers, pet food producers, and aquaculture farms. This represents a significant portion of their business operations and highlights their role in supporting the food production industry.
Beyond fish-based products, Mukka Proteins has expanded its offerings to include insect meal and insect oil. This diversification reflects a growing trend towards sustainable and alternative protein sources within the animal feed industry. The inclusion of insect-derived products demonstrates Mukka Proteins' commitment to innovation and adapting to evolving market demands.
The applications of Mukka Proteins' products extend beyond animal feed. Their diverse product range also finds use in various other industries, including pharmaceuticals, soap manufacturing, leather tanning, and even the paint industry. This broad application demonstrates the versatility and value of their products across multiple sectors, contributing to their robust business model.
Mukka Proteins has established a significant international presence, exporting its products to a wide array of countries including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. This global reach underscores the company's success in meeting the international demand for high-quality protein ingredients.
With a history dating back to 1960, Mukka Proteins (formerly Mukka Sea Food Industries Limited) has a long-standing presence in the industry. Based in Mangalore, India, the company continues to build upon its legacy of providing essential ingredients to a broad range of industries, both domestically and across international markets.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Avanti Feeds (AVANTIFEED) Share PricePeer
- Godrej Agrovet (GODREJAGRO) Share PricePeer
- Narmada Agrobase (NARMADA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Mukka Proteins Limited (MUKKA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Mukka Proteins Limited (MUKKA)?
The current share price of Mukka Proteins Limited (MUKKA) is ₹22.58. Today, the stock has declined by ₹0.36 (1.57%), trading in a range of ₹21.5 to ₹23.49. The stock opened at ₹23.01 with a trading volume of 3,34,728 shares.
02Is Mukka Proteins Limited stock a good investment for long-term?
Mukka Proteins Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹686.4 crores, P/E ratio of 13.29, ROE of 11.10%, and ROCE of 11.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Mukka Proteins Limited stock?
The 52-week high price of Mukka Proteins Limited (MUKKA) is ₹31.23, while the 52-week low is ₹18.27. Currently trading at ₹22.58, the stock is 33.3% away from its 52-week low and 27.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Mukka Proteins Limited stock at the current price?
Whether to buy Mukka Proteins Limited stock at ₹22.58 depends on multiple factors. The stock is currently trading with a P/E ratio of 13.29 and P/B ratio of 1.39. Today's performance shows a loss of 1.57%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Mukka Proteins Limited and when is the next dividend?
Mukka Proteins Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹22.58, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Mukka Proteins Limited?
Mukka Proteins Limited's key financial metrics include: P/E Ratio: 13.29, P/B Ratio: 1.39, ROE: 11.10%, ROCE: 11.60%, Dividend Yield: 0.00%, EPS: ₹1.74, Book Value: ₹16.71, and Debt-to-Equity: 1.56. The company's market cap stands at ₹686.4 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Mukka Proteins Limited stock performing today in the market?
Mukka Proteins Limited stock opened at ₹23.01 and is currently trading at ₹22.58, showing a decline of ₹0.36 (1.57%). The intraday high is ₹23.49 and low is ₹21.5. The trading volume stands at 3,34,728 shares, indicating moderate market participation today.
08What is the P/E ratio of Mukka Proteins Limited and what does it indicate?
Mukka Proteins Limited has a Price-to-Earnings (P/E) ratio of 13.29, which means investors are willing to pay ₹13.29 for every ₹1 of earnings. With an EPS of ₹1.74, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Mukka Proteins Limited (MUKKA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.